The Japan Times - US abortion ruling threatens access to arthritis drug

EUR -
AED 3.820007
AFN 78.453661
ALL 98.266065
AMD 418.855353
ANG 1.881468
AOA 950.067495
ARS 1089.177597
AUD 1.661397
AWG 1.874656
AZN 1.778959
BAM 1.955125
BBD 2.107772
BDT 127.306036
BGN 1.955445
BHD 0.392015
BIF 3088.992654
BMD 1.040031
BND 1.412639
BOB 7.213509
BRL 6.18621
BSD 1.043939
BTN 90.253964
BWP 14.439014
BYN 3.41632
BYR 20384.60441
BZD 2.096976
CAD 1.496552
CDF 2958.887899
CHF 0.943937
CLF 0.037364
CLP 1030.992715
CNY 7.579535
CNH 7.584778
COP 4431.571397
CRC 525.023737
CUC 1.040031
CUP 27.560817
CVE 110.226934
CZK 25.145864
DJF 185.895803
DKK 7.459827
DOP 64.058494
DZD 140.850005
EGP 52.366802
ERN 15.600463
ETB 133.537568
FJD 2.40923
FKP 0.856556
GBP 0.845509
GEL 2.974719
GGP 0.856556
GHS 15.815538
GIP 0.856556
GMD 75.922434
GNF 9024.057179
GTQ 8.069136
GYD 218.304611
HKD 8.101866
HNL 26.577077
HRK 7.674957
HTG 136.325543
HUF 410.937046
IDR 16926.397873
ILS 3.698667
IMP 0.856556
INR 89.976708
IQD 1367.514596
IRR 43785.29838
ISK 146.103649
JEP 0.856556
JMD 163.805007
JOD 0.737692
JPY 162.709713
KES 134.528257
KGS 90.950463
KHR 4208.627531
KMF 491.522055
KPW 936.027869
KRW 1496.661555
KWD 0.320569
KYD 0.87
KZT 543.812201
LAK 22771.136248
LBP 93483.616501
LKR 311.742343
LRD 206.696632
LSL 19.287239
LTL 3.070941
LVL 0.629104
LYD 5.135227
MAD 10.416603
MDL 19.469277
MGA 4893.357185
MKD 61.558788
MMK 3377.97959
MNT 3534.024896
MOP 8.374128
MRU 41.580041
MUR 48.371921
MVR 16.02691
MWK 1810.192276
MXN 21.31668
MYR 4.622419
MZN 66.4683
NAD 19.287239
NGN 1621.32462
NIO 38.417472
NOK 11.743778
NPR 144.409518
NZD 1.839639
OMR 0.400329
PAB 1.043939
PEN 3.893818
PGK 4.250573
PHP 61.043047
PKR 291.099072
PLN 4.222681
PYG 8257.148488
QAR 3.810084
RON 4.975522
RSD 117.110626
RUB 102.963513
RWF 1464.608297
SAR 3.901242
SBD 8.813979
SCR 14.823166
SDG 625.058472
SEK 11.469788
SGD 1.411213
SHP 0.856556
SLE 23.604267
SLL 21808.926559
SOS 596.599707
SRD 36.484374
STD 21526.538517
SVC 9.134845
SYP 13522.48093
SZL 19.272345
THB 35.354288
TJS 11.425644
TMT 3.650508
TND 3.313456
TOP 2.435857
TRY 37.084676
TTD 7.091551
TWD 34.109926
TZS 2636.478428
UAH 43.84588
UGX 3841.673322
USD 1.040031
UYU 45.684663
UZS 13560.317099
VES 57.920838
VND 26141.175094
VUV 123.474549
WST 2.912946
XAF 655.736854
XAG 0.03405
XAU 0.000378
XCD 2.810735
XDR 0.80433
XOF 655.730551
XPF 119.331742
YER 259.020115
ZAR 19.310726
ZMK 9361.526229
ZMW 29.099951
ZWL 334.889505
  • RBGPF

    61.2800

    61.28

    +100%

  • RYCEF

    0.1500

    7.42

    +2.02%

  • RELX

    -0.2900

    49.26

    -0.59%

  • SCS

    -0.2200

    11.58

    -1.9%

  • NGG

    -1.5400

    60.05

    -2.56%

  • GSK

    -0.3500

    33.43

    -1.05%

  • RIO

    -0.6100

    61.12

    -1%

  • BP

    -0.3900

    31.13

    -1.25%

  • CMSC

    -0.0600

    23.49

    -0.26%

  • CMSD

    -0.0400

    23.96

    -0.17%

  • BTI

    -0.1600

    36.57

    -0.44%

  • VOD

    -0.1700

    8.38

    -2.03%

  • BCC

    -1.2000

    127.92

    -0.94%

  • BCE

    -0.2400

    23.15

    -1.04%

  • JRI

    -0.0400

    12.53

    -0.32%

  • AZN

    0.2400

    68.2

    +0.35%

US abortion ruling threatens access to arthritis drug
US abortion ruling threatens access to arthritis drug / Photo: Andy Buchanan - POOL/AFP/File

US abortion ruling threatens access to arthritis drug

When Alabama nurse Melissa went to pick up her regular prescription for rheumatoid arthritis last week, she was told the drug was "on hold" while the pharmacist checked she wasn't going to use it to induce an abortion.

Text size:

"He said, 'Well I have to verify if you're on any contraceptives to prevent pregnancy.' The hell you do," she recalled thinking.

Melissa -- who is in her early forties and asked to be identified only by her first name for fear that speaking out might affect her livelihood -- then called her doctor, who succeeded in having the pharmacy in the southern US state release the medicine.

"I picked it up a couple hours later, but I felt violated," she told AFP, explaining she had had a hysterectomy six years ago, and that her lack of recent contraceptive history may have led the pharmacist to suspect she was pregnant.

Stories of people facing similar struggles have come to light in the weeks since the United States Supreme Court overturned Roe v Wade on June 24, highlighting an overlooked consequence of new state-level bans or severe restrictions on abortion.

It's not yet clear how widespread the cases are, but national organizations including the Lupus Foundation of America and the American College of Rheumatology said they were aware of such concerns and asking people affected to come forward.

"The Arthritis Foundation supports unencumbered access to and coverage of FDA-approved drugs for managing arthritis in alignment with scientific and clinical guidelines, as well as evidence-based medical recommendations," the organization said.

The issue centers on methotrexate, a drug which tempers inflammation and is commonly used against autoimmune conditions including inflammatory arthritis, psoriasis and lupus.

Methotrexate stops cell division and is given in higher doses as a cancer drug.

It can also sometimes be used in medical abortions, though not as frequently as the Food and Drug Administration-approved combination of two other drugs, mifepristone and misoprostol.

Nevertheless, many states have passed laws carrying threats of legal action against health care workers and pharmacies providing methotrexate.

- 'It's terrifying' -

Another woman contacted by AFP, a 20-year-old university student from Ohio, said she has had a methotrexate prescription since 2020 to treat her lupus, which affects her kidney and liver and causes joint pain.

A pharmacist at a national chain told her they were "no longer accepting prescriptions for methotrexate unless it was for the FDA-approved use of (treating) breast cancer, or the patient was not presumably fertile," she said.

She tried again, without success, to fill her prescription at a family-owned pharmacy, and this week got a letter from her doctor's office stating the practice would no longer be prescribing methotrexate because of the number of patients having difficulty accessing it.

Though the first pharmacy later changed its position, the experience left her "annoyed and angry," she said.

A third woman, 48-year-old Jennifer Crow, a writer and produce gardener in Tellico Plains, Tennessee, told AFP she received an automated call from CVS saying her methotrexate refill had been declined "pending provider approval."

Crow said Methotrexate had helped her enormously in managing her inflammatory arthritis, allowing her to roll out of bed and get dressed without severe pain, and walk without a cane for the first time in years.

Though her doctor was able to resolve the situation, Crow, who has also had a hysterectomy, said she was worried for other chronic illness patients who didn't have the same access to resources that she does.

In statements to AFP, national pharmacy chains CVS and Walmart confirmed they were working to adhere to new state regulations in light of the high court's decision to revoke the constitutional right to an abortion.

CVS added: "We encourage providers to include their diagnosis on the prescriptions they write to help ensure patients have quick and easy access to medications."

Alisa Vidulich, policy director of the Arthritis Foundation, told AFP she was hopeful the situation might be remedied quickly as medical professionals and pharmacies developed new guidelines.

"But that may not actually be the case in all states and it may in fact turn into a longer term issue," she acknowledged.

Melissa, the nurse, said she was incensed at the double standard that allowed one of her best friends, who is a man, to get his methotrexate prescription filled right away with no questions asked.

"We're headed in the wrong direction and it's terrifying. I have two daughters. I don't want to see this," she said.

M.Fujitav--JT